Drug Profile
PF 2391677
Alternative Names: PF-2391677Latest Information Update: 14 May 2009
Price :
$50
*
At a glance
- Originator Pfizer
- Class Digestion aids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastro-oesophageal reflux
Most Recent Events
- 28 Feb 2008 Phase-I clinical trials in Gastro-oesophageal reflux in United Kingdom (unspecified route)